Michael Hiltzik: Those drug prices Big Pharma cut to appease Trump? Drugmakers are raising them again
It's hard to believe that anyone was taken in this summer when a handful of drug companies announced rollbacks of price increases or price freezes on some of their drugs, ostensibly in response to jawboning by President Trump.
The Washington Post declared that Pfizer's July 10 announcement that it would hold off on already scheduled price hikes was "a successful use of the bully pulpit for Trump and a relatively rapid concession by one of the country's largest companies."
Trump himself bought into the narrative, and why not, since it
